title: Didronel PMO.
abstract: Didronel PMO is a new treatment, comprising cyclical disodium etidronate and calcium carbonate, for women with postmenopausal osteoporosis who already have one or more vertebral fractures. Vertebral fracture rates can be reduced by 50% after treatment for 2 years.
authors.affiliation: Cardiff Royal Infirmary.
authors.forename: M
authors.initials: M
authors.lastname: Stone
mesh_terms: D000368:Aged; D002119:Calcium Carbonate / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D016527:Drug Costs; D004359:Drug Therapy, Combination; D012968:Etidronic Acid / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D012307:Risk Factors; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D002119:Calcium Carbonate; D012968:Etidronic Acid